Amneal Pharmaceuticals (AMRX) Profit After Tax (2017 - 2026)
Amneal Pharmaceuticals' Profit After Tax was $69.61 million in Q2 2026, up 95.5% from $35.61 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Profit After Tax (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amneal Pharmaceuticals' Profit After Tax was $215.32 million through Jun 30, 2026, up 320.2% year-over-year; for FY2025, it was $127.93 million.
- Profit After Tax shows a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- In earlier years, Profit After Tax was -$73.88 million in FY2024, -$48.72 million in FY2023, -$254.83 million in FY2022 and $20.17 million in FY2021 (-70.6%).
- Quarterly Profit After Tax has moved between -$240.13 million (Q2 2022) and $78 million (Q1 2026) over five years.
- Compared with a year earlier, Profit After Tax was higher in four of the last five quarters, with growth averaging 85.1%.
- Per Business Quant data, AMRX's Profit After Tax in the three quarters before Q2 2026 was $78 million (Q1 2026), $49.57 million (Q4 2025) and $18.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 5.28 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.09 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Amneal Pharmaceuticals | 6.48 Bn | 5.76 Bn | 334.51 Mn | 69.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 18.13 Mn |
| Jun 30, 2025 | 35.61 Mn |
| Mar 31, 2025 | 24.62 Mn |
| Dec 31, 2024 | -20.74 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 16.79 Mn |
| Mar 31, 2024 | -81.68 Mn |
| Dec 31, 2023 | -93.34 Mn |
| Sep 30, 2023 | 25.06 Mn |
| Jun 30, 2023 | 29.68 Mn |
| Mar 31, 2023 | -10.13 Mn |
| Dec 31, 2022 | -5.86 Mn |
| Sep 30, 2022 | -2.42 Mn |
| Jun 30, 2022 | -240.13 Mn |
| Mar 31, 2022 | -6.42 Mn |
| Dec 31, 2021 | -20.42 Mn |
| Sep 30, 2021 | -6.09 Mn |
API Access
Amneal Pharmaceuticals Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();